APA

Durez P., Pavelka K., Lazaro M. A., Garcia-Kutzbach A., Moots R. J., Amital H., Govoni M. & Vastesaeger N. (20180918). Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. : Clinical rheumatology.

Chicago

Durez Patrick, Pavelka Karel, Lazaro Maria Alicia, Garcia-Kutzbach Abraham, Moots Robert J, Amital Howard, Govoni Marinella and Vastesaeger Nathan. 20180918. Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. : Clinical rheumatology.

Harvard

Durez P., Pavelka K., Lazaro M. A., Garcia-Kutzbach A., Moots R. J., Amital H., Govoni M. and Vastesaeger N. (20180918). Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. : Clinical rheumatology.

MLA

Durez Patrick, Pavelka Karel, Lazaro Maria Alicia, Garcia-Kutzbach Abraham, Moots Robert J, Amital Howard, Govoni Marinella and Vastesaeger Nathan. Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. : Clinical rheumatology. 20180918.